Document is current
Any future updates will be listed below
-
Authors
Silginer, M
Burghardt, I
Gramatzki, D
Bunse, L
Leske, H
Rushing, E J
Hao, N
Platten, M
Weller, M
Roth, P
- License Information
-
More Information
Article History
Received: 11 March 2015
Revised: 31 August 2015
Accepted: 8 September 2015
First Online: 26 October 2015
Competing interests
: PR has received honoraria for lectures or advisory board participation from MSD, Roche, Novartis and Molecular Partners. MW has received research grants from Acceleron, Actelion, Alpinia Institute, Bayer, Isarna, MSD, Merck & Co, Novocure, PIQUR and Roche and honoraria for lectures or advisory board participation or consulting from Celldex, Immunocellular, Isarna, Magforce, MSD, Merck & Co, Northwest Biotherapeutics, Novocure, Pfizer, Roche and Teva. MP has received research grants from Bayer, Merck, Novartis and Nuon Biotherapeutics and honoraria for lectures or advisory board participation or consulting from Bayer, Merck, Novartis, Roche, Alexion, MSD, iTEOS and Miltenyi.
